
Total Cannabis capital raises are down 67% YTD compared to 2021. The decline has been particularly steep in equity raises (U.S. down 73% and Canada down 94%), but debt financing has also suffered (U.S. up 72%, Canada down 86% for a total decline of 33%).
-
The reason for the equity decline is apparent. The MSOS ETF, a widely used cannabis stock indicator, is down 40.0% YTD, and valuation multiples have declined accordingly. Last week’s Viridian Capital Chart of the Week showed that cannabis MSOs are now trading well below intrinsic value. No CFO wants to sell stock at such low prices, particularly if there is still any glimmer of hope that a positive legislative result could produce an upside catalyst.